Results 161 to 170 of about 26,437 (217)

Pleomorphic Carcinoma With EGFR and Concomitant Mutations Transformed From Lung Adenocarcinoma: A Case Report. [PDF]

Cancer Rep (Hoboken)
Akazawa Y, Sato T, Yagami Y, Kesen Y, Furo T, Watanabe A, Endo J, Nakano M, Kurata H, Matsuo H, Nakahara Y, Sasaki J, Naoki K.   +12 more
europepmc   +1 more source

From genes to therapy: navigating the complex landscape of neurofibromatosis management in Canada through advanced diagnostic, targeted therapies, and holistic care. [PDF]

Orphanet J Rare Dis
Zhao VSC.
europepmc   +1 more source

The genotypic and family characteristics and clinical intervention of neurofibromatosis type 1 gene are associated with dystrophic scoliosis by whole-exome sequencing. [PDF]

Front Neurol
Du Y, Bai T, Song J, Zhang L, Huang H, Han P, Gai F, Guo J, Li J, Lv C, Shao J, Zhang G, Tao H, Xi Y.   +13 more
europepmc   +1 more source

Unraveling cardiac anomalies in pediatric neurofibromatosis type 1: insights and implications. [PDF]

Eur J Pediatr
Yahia S, Abdelmoneim Z, Ghozzy D, Wahba Y, Abo-Haded HM.   +4 more
europepmc   +1 more source

Regulator of chromosome condensation 1 and broad-complex, tramtrack and bric a brac domain-containing protein is involved in ovarian cancer growth and drug resistance. [PDF]

Cytojournal
Zhao G, Xiao X, Song L, Qi B.
europepmc   +1 more source

Minimal Change Disease in a Young Adult With Neurofibromatosis Type 1. [PDF]

Cureus
Clissa PB, da Costa CML, Sanabani SS.
europepmc   +1 more source

Neurofibromin Encoded by the Neurofibromatosis Type 1 (NF1) Gene Promotes the Membrane Translocation of SPRED2, Thereby Inhibiting the ERK Pathway in Breast Cancer Cells. [PDF]

Int J Mol Sci
Su Pwint NT, Li C, Gao T, Wang Y, Fujisawa M, Ohara T, Sakaguchi M, Yoshimura T, Matsukawa A.   +8 more
europepmc   +1 more source

Refined genotype-phenotype correlations in neurofibromatosis type 1 patients with <i>NF1</i> point variants. [PDF]

J Med Genet
Pacot L, Blok M, Vidaud D, Fertitta L, Laurendeau I, Coustier A, Maillard T, Barbance C, Hadjadj D, Ye M, Lallemand D, Ferkal S, Funalot B, Lunati-Rozie A, Hebrard B, Bhouri R, Spruijt L, Bessis D, Geneviève D, Vernimmen V, Broen MPG, Sigaudy S, Odent S, Damaj L, Quélin C, Pasquier L, Layet V, Gilbert-Dussardier B, Nicolas G, Guerrot AM, Leheup B, Bursztejn AC, Petit F, Boute-Bénéjean O, Capri Y, Guimier A, Lyonnet S, Baujat G, Bourrat E, Isidor B, Nizon M, Barbarot S, Toutain A, Blesson S, Van-Gils J, Morice-Picard F, Audebert-Bellanger S, Mazereeuw-Hautier J, Ziegler A, Alembik Y, Piard J, Brischoux-Boucher E, Guerrini-Rousseau L, Morera J, Paquis-Flucklinger V, Delobel B, Alessandri JL, Parfait B, NF-France network, Wolkenstein P, Pasmant E.   +60 more
europepmc   +1 more source

Neurofibromatosis Type 1 and MEK Inhibition: A Comprehensive Review with Focus on Selumetinib Therapy. [PDF]

J Clin Med
Imataka G, Kuwashima S, Hayashi S, Ogino K, Hoshiyama E, Naruse K, Shiraishi H.   +6 more
europepmc   +1 more source